Table of contents
Volume 95, Issue 2
Published online 11 July 2006 (131-245)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letter to the Editor |
Corrigendum
Minireview
Management of advanced colorectal cancer: state of the art FREE
M Saunders and T Iveson
Br J Cancer 95: 131-138; doi:10.1038/sj.bjc.6603233
Clinical Studies
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results FREE
C Mascaux, B Martin, M Paesmans, T Berghmans, M Dusart, A Haller, P Lothaire, A-P Meert, J-J Lafitte and J-P Sculier
Br J Cancer 95: 139-145; advance online publication, June 20, 2006; doi:10.1038/sj.bjc.6603226
Personality traits and cancer survival: a Danish cohort study FREE
N Nakaya, P E Hansen, I R Schapiro, L F Eplov, K Saito-Nakaya, Y Uchitomi and C Johansen
Br J Cancer 95: 146-152; advance online publication, July 4, 2006; doi:10.1038/sj.bjc.6603244
Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids FREE
G Francini, R Petrioli, A Montagnani, A Cadirni, S Campagna, E Francini and S Gonnelli
Br J Cancer 95: 153-158; doi:10.1038/sj.bjc.6603258
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer FREE
Y Chao, C P Li, T Y Chao, W C Su, R K Hsieh, M F Wu, K H Yeh, W Y Kao, L T Chen and A L Cheng
Br J Cancer 95: 159-163; advance online publication, June 27, 2006; doi:10.1038/sj.bjc.6603225
Translational Therapeutics
STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines FREE
W Zhou, J R Grandis and A Wells
Br J Cancer 95: 164-171; advance online publication, June 27, 2006; doi:10.1038/sj.bjc.6603234
Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells FREE
H E Jones, J M W Gee, D Barrow, D Tonge, B Holloway and R I Nicholson
Br J Cancer 95: 172-180; advance online publication, July 4, 2006; doi:10.1038/sj.bjc.6603237
Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma FREE
D J Gottlieb, Y-C Li, I Lionello, S Tanzarella, M Marangolo, K F Bradstock, V Russo and C Traversari
Br J Cancer 95: 181-188; advance online publication, July 4, 2006; doi:10.1038/sj.bjc.6603243
Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells FREE
R Laptev, M Nisnevitch, G Siboni, Z Malik and M A Firer
Br J Cancer 95: 189-196; advance online publication, July 4, 2006; doi:10.1038/sj.bjc.6603241
A pilot clinical study of 
9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme FREE
M Guzmán, M J Duarte, C Blázquez, J Ravina, M C Rosa, I Galve-Roperh, C Sánchez, G Velasco and L González-Feria
Br J Cancer 95: 197-203; advance online publication, June 27, 2006; doi:10.1038/sj.bjc.6603236
Molecular Diagnostics
Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology FREE
A Carpi, A G Naccarato, G Iervasi, A Nicolini, G Bevilacqua, P Viacava, P Collecchi, L Lavra, C Marchetti, S Sciacchitano and A Bartolazzi
Br J Cancer 95: 204-209; advance online publication, June 27, 2006; doi:10.1038/sj.bjc.6603232
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4 FREE
C C Schimanski, R Bahre, I Gockel, A Müller, K Frerichs, V Hörner, A Teufel, N Simiantonaki, S Biesterfeld, T Wehler, M Schuler, T Achenbach, T Junginger, P R Galle and M Moehler
Br J Cancer 95: 210-217; advance online publication, July 4, 2006; doi:10.1038/sj.bjc.6603251
Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT–PCR FREE
L Ohlsson, M-L Hammarström, A Israelsson, L Näslund, Å Öberg, G Lindmark and S Hammarström
Br J Cancer 95: 218-225; advance online publication, June 6, 2006; doi:10.1038/sj.bjc.6603206
Human papillomavirus infection: an Anonymous Prevalence Study in South Wales, UK FREE
S Hibbitts, G C Rieck, K Hart, N G Powell, R Beukenholdt, N Dallimore, J McRea, A Hauke, A Tristram and A N Fiander
Br J Cancer 95: 226-232; advance online publication, July 4, 2006; doi:10.1038/sj.bjc.6603245
Genetics and Genomics
A prospective study of neurofibromatosis type 1 cancer incidence in the UK FREE
L Walker, D Thompson, D Easton, B Ponder, M Ponder, I Frayling and D Baralle
Br J Cancer 95: 233-238; advance online publication, June 20, 2006; doi:10.1038/sj.bjc.6603227
Association of MUTYH and colorectal cancer FREE
A Tenesa, H Campbell, R Barnetson, M Porteous, M Dunlop and S M Farrington
Br J Cancer 95: 239-242; advance online publication, June 27, 2006; doi:10.1038/sj.bjc.6603239
Letter to the Editor
Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness FREE
M Tischkowitz, A Gologan, H Srolovitz, M Khanna and W D Foulkes
Br J Cancer 95: 243-244; advance online publication, June 20, 2006; doi:10.1038/sj.bjc.6603228
Corrigendum
Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition FREE
D Krubasik, N G Iyer, W R English, A A Ahmed, M Vias, C Roskelley, J D Brenton, C Caldas and G Murphy
Br J Cancer 95: 245; doi:10.1038/sj.bjc.6603202
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
